TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 12577430

Group type: EXPERIMENTAL
Intervention: Naoreqing (NRQ) oral liquid
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Naoreqing (NRQ) oral liquid plus western medicine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Western medicine alone
Number of subjects: 0
Study: 9701524

Group type: EXPERIMENTAL
Intervention: Clarithromycin 500 mg b.d. (group PMC 500)
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: Clarithromycin 250 mg b.d. (group PMC 250)
Number of subjects: 163
Study: 8027495

Group type: EXPERIMENTAL
Intervention: Benzyl benzoate
Number of subjects: 12

Group type: COMPARATOR
Intervention: Baking soda
Number of subjects: 12
Study: 2589358

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin
Number of subjects: 68

Group type: COMPARATOR
Intervention: Clindamycin plus Gentamicin
Number of subjects: 68
Study: 922326

Group type: EXPERIMENTAL
Intervention: Proximal gastric vagotomy (PGV)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Proximal gastric vagotomy with pyloroplasty (PGVP)
Number of subjects: 100
Study: 31954998

Group type: EXPERIMENTAL
Intervention: Perampanel 8 mg/day
Number of subjects: 372

Group type: EXPERIMENTAL
Intervention: Perampanel 12 mg/day
Number of subjects: 372

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 372

Group type: EXPERIMENTAL
Intervention: Treatment-emergent adverse events (TEAEs)
Number of subjects: 372

Group type: EXPERIMENTAL
Intervention: Serious TEAEs
Number of subjects: 372
Study: 31481813

Group type: EXPERIMENTAL
Intervention: All-acrylic removable partial dentures (RPD)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Flexible removable partial dentures (RPD)
Number of subjects: 30
Study: 29036256

Group type: COMPARATOR
Intervention: Oral minocycline HCl extended-release tablets (approximately 1 mg/kg)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Topical minocycline foam 4% (4-g maximal-use dose) applied once daily for 21 days
Number of subjects: 30
Study: 24336330

Group type: EXPERIMENTAL
Intervention: CAF-specific TGFBR2 expression
Number of subjects: 564

Group type: EXPERIMENTAL
Intervention: CAF-specific pSMAD2 levels
Number of subjects: 564

Group type: EXPERIMENTAL
Intervention: TGFBR2 knockdown in CAFs
Number of subjects: 564

Group type: EXPERIMENTAL
Intervention: Mouse model with TGFBR2 knockdown fibroblasts
Number of subjects: 564
Study: 23749624

Group type: EXPERIMENTAL
Intervention: PARZIVAR intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 0
Study: 22141447

Group type: EXPERIMENTAL
Intervention: CHD prevention intervention (computerized decision aid and automated tailored adherence messages)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 160
Study: 19221257

Group type: EXPERIMENTAL
Intervention: Whole-body irradiated with a 0.7-MED of UV-B daily on 10 consecutive days followed by a single dose of 3 MEDs on a small body area
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Whole body irradiated with 120 J/m2 solar-simulated radiation for 10 consecutive days, then single-dose UV-B exposure of 3 MEDs on a small body area after 24 hours
Number of subjects: 98

Group type: COMPARATOR
Intervention: Irradiated with a single UV-B dose of 3 MEDs on a small body area
Number of subjects: 98

Group type: COMPARATOR
Intervention: Irradiated with a single UV-B dose of 4 MEDs on a small body area
Number of subjects: 98
Study: 17033263

Group type: EXPERIMENTAL
Intervention: Measurement of serum IGF-I concentrations
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Auxological data evaluation (growth rate and growth)
Number of subjects: 0
Study: 14656270

Group type: EXPERIMENTAL
Intervention: Adjuvant platinum-containing chemotherapy
Number of subjects: 924

Group type: COMPARATOR
Intervention: Observation following surgery
Number of subjects: 924
Study: 11720165

Group type: EXPERIMENTAL
Intervention: PNF movement with hip internal rotation
Number of subjects: 6

Group type: COMPARATOR
Intervention: Other exercises (not specified)
Number of subjects: 6
Study: 9209998

Group type: EXPERIMENTAL
Intervention: Polypropylene haptic IOL
Number of subjects: 156

Group type: COMPARATOR
Intervention: All PMMA IOL
Number of subjects: 156
Study: 7510316

Group type: EXPERIMENTAL
Intervention: Tianeptine 12.5 mg single dose and 12 weeks treatment up to 37.5 mg daily
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tianeptine in elderly patients
Number of subjects: 0
Study: 3774011

Group type: EXPERIMENTAL
Intervention: Short course of chemotherapy (cyclophosphamide, 5 mg/kg/day for 6 days iv)
Number of subjects: 507

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 507

Group type: EXPERIMENTAL
Intervention: Continued chemotherapy for 1 year (for node-positive patients)
Number of subjects: 507
Study: 31729625

Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Number of subjects: 52

Group type: COMPARATOR
Intervention: Chemotherapy
Number of subjects: 52
Study: 31263526

Group type: EXPERIMENTAL
Intervention: Buprenorphine
Number of subjects: 100

Group type: COMPARATOR
Intervention: Buprenorphine/naloxone
Number of subjects: 100
Study: 27458288

Group type: EXPERIMENTAL
Intervention: Selinexor (60 mg flat dose) administered twice per week (days 1 and 3) on a 3 weeks on, 1 week off schedule
Number of subjects: 54
Study: 25161024

Group type: EXPERIMENTAL
Intervention: 4% albumin
Number of subjects: 13577

Group type: EXPERIMENTAL
Intervention: 6% hydroxyethyl starch (HES) 130/0.4
Number of subjects: 13577

Group type: COMPARATOR
Intervention: 0.9% saline
Number of subjects: 13577
Study: 23052111

Group type: EXPERIMENTAL
Intervention: tranexamic acid
Number of subjects: 72

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 72
Study: 20658454

Group type: EXPERIMENTAL
Intervention: Ultrahigh-pressure (UHP) angioplasty
Number of subjects: 22

Group type: COMPARATOR
Intervention: Peripheral Cutting Balloon (PCB) angioplasty
Number of subjects: 22
Study: 20467648

Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen therapy (HBO)
Number of subjects: 26

Group type: COMPARATOR
Intervention: No HBO therapy
Number of subjects: 26
Study: 16892928

Group type: EXPERIMENTAL
Intervention: Clean intermittent catheterization technique
Number of subjects: 36

Group type: COMPARATOR
Intervention: Sterile intermittent catheterization technique
Number of subjects: 36
Study: 12659243

Group type: EXPERIMENTAL
Intervention: Stabilized oxygen dissolved in water
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Rhodiola rosea
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 10321398

Group type: EXPERIMENTAL
Intervention: GPs who check the accuracy of invitation lists
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: GPs who follow up non-attendees for screening
Number of subjects: 158
Study: 8876070

Group type: EXPERIMENTAL
Intervention: 5 mg cetirizine (CTZ)
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: 120 mg pseudoephedrine retard (PER)
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Combination of 5 mg cetirizine and 120 mg pseudoephedrine retard (COM)
Number of subjects: 210
Study: 1362377

Group type: EXPERIMENTAL
Intervention: Somatostatin or octreotide
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Glypressin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vasopressin and nitroglycerin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vasoactive agents
Number of subjects: 0
Study: 3925486

Group type: EXPERIMENTAL
Intervention: Naloxone (1.2 mg IV)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Diazepam (0.25 mg/kg oral)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Naloxone + Diazepam
Number of subjects: 10
Study: 31246055

Group type: EXPERIMENTAL
Intervention: Accounts explaining why a company layoff was made
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Accounts describing how layoff recipients were treated respectfully
Number of subjects: 0
Study: 29554966

Group type: EXPERIMENTAL
Intervention: Workshops using cadaveric dislocation models
Number of subjects: 146

Group type: COMPARATOR
Intervention: Instructional cards
Number of subjects: 146

Group type: COMPARATOR
Intervention: Cadaveric instruction on the relocation of one-, two- or all three-joints
Number of subjects: 146

Group type: COMPARATOR
Intervention: Skeleton model instruction
Number of subjects: 146
Study: 26710675

Group type: EXPERIMENTAL
Intervention: Plus version of the intervention (targeting environmental-level factors)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Basic version of the intervention (targeting individual cognitions and self-regulation)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (generic nutrition information)
Number of subjects: 100
Study: 25134038

Group type: EXPERIMENTAL
Intervention: 12-step facilitative intervention
Number of subjects: 234

Group type: EXPERIMENTAL
Intervention: Baseline variables (122 total)
Number of subjects: 234
Study: 21999668

Group type: EXPERIMENTAL
Intervention: Neuromuscular electrical stimulation (NMES) to the wrist extensors, pulsed current, 100 Hz, pulse duration of 0.1 msec, resting duration of 9 seconds, for 15 minutes, combined with stretching.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Stretching of the wrist extensor muscles alone.
Number of subjects: 0
Study: 20454667

Group type: EXPERIMENTAL
Intervention: Video-based intervention for non-gay identified MSM
Number of subjects: 329

Group type: COMPARATOR
Intervention: Text-based intervention for non-gay identified MSM
Number of subjects: 329

Group type: EXPERIMENTAL
Intervention: Video-based intervention for gay-identified MSM
Number of subjects: 329

Group type: COMPARATOR
Intervention: Text-based intervention for gay-identified MSM
Number of subjects: 329
Study: 18559301

Group type: EXPERIMENTAL
Intervention: Valerian/hops fluid extract (2 ml diluted in 50 ml water, administered 15 minutes before EEG recording)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo (similar smelling placebo, 2 ml diluted in 50 ml water, administered 15 minutes before EEG recording)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Valerian/hops fluid extract
Number of subjects: 42
Study: 17402322

Group type: EXPERIMENTAL
Intervention: Laparoscopic cholecystectomy (LC)
Number of subjects: 157

Group type: COMPARATOR
Intervention: Minilaparotomy cholecystectomy (MC)
Number of subjects: 157
Study: 15321024

Group type: EXPERIMENTAL
Intervention: Travoprost 0.004%
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Bimatoprost 0.03%
Number of subjects: 19

Group type: COMPARATOR
Intervention: Brimonidine 0.2%
Number of subjects: 19

Group type: COMPARATOR
Intervention: Betaxolol 0.25%
Number of subjects: 19
Study: 11217678

Group type: EXPERIMENTAL
Intervention: 25 mg DKPT t.i.d. (n = 97)
Number of subjects: 192

Group type: COMPARATOR
Intervention: 50 mg TRAM t.i.d. (n = 95)
Number of subjects: 192
Study: 9291421

Group type: EXPERIMENTAL
Intervention: BAY x 7195 (500 mg, single oral dose)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 8326271

Group type: EXPERIMENTAL
Intervention: Experimental group (AIDS education programme)
Number of subjects: 337

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 337

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 337
Study: 2873760

Group type: EXPERIMENTAL
Intervention: Atracurium, 0.5 mg/kg
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Atracurium, 1.0 mg/kg
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Vecuronium, 0.1 mg/kg
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Vecuronium, 0.2 mg/kg
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Atracurium, 1.0 mg/kg (rapid sequence induction)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Vecuronium, 0.2 mg/kg (rapid sequence induction)
Number of subjects: 60
Study: 29470308

Group type: EXPERIMENTAL
Intervention: IAI 2 mg every 4 weeks (2q4)
Number of subjects: 403

Group type: EXPERIMENTAL
Intervention: IAI 2 mg every 4 weeks until Week 16 then 8-week dosing (2q8)
Number of subjects: 403

Group type: COMPARATOR
Intervention: Laser
Number of subjects: 403

Group type: EXPERIMENTAL
Intervention: IAI 2q8 in VIVID-Japan
Number of subjects: 403
Study: 26927286

Group type: EXPERIMENTAL
Intervention: Acetaminophen 4g daily for 7 days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo pills
Number of subjects: 0
Study: 25464065

Group type: EXPERIMENTAL
Intervention: Large portion labeled as 'Contains 4 servings'
Number of subjects: 100

Group type: COMPARATOR
Intervention: Large portion labeled as 'Contains 2 servings'
Number of subjects: 100

Group type: COMPARATOR
Intervention: Large portion unlabeled
Number of subjects: 100

Group type: COMPARATOR
Intervention: Small portion
Number of subjects: 100
Study: 23233708

Group type: EXPERIMENTAL
Intervention: Video decision support tool (3-minute video depicting CPR)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Verbal narrative describing CPR
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Video decision support tool (3-minute video)
Number of subjects: 150
Study: 21696108

Group type: EXPERIMENTAL
Intervention: Pendulum appliance
Number of subjects: 30

Group type: COMPARATOR
Intervention: Cervical headgear (CHG)
Number of subjects: 30
Study: 19111270

Group type: EXPERIMENTAL
Intervention: Diagram method (patients viewed a set of diagrams illustrating the 12 key points before signing the informed-consent form)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Teach-the-teacher method (patients had to repeat the 12 key points to the physicians before informed consent was complete)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Control group (informed consent obtained in the customary manner with 12 key points discussed conversationally)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Teach-the-teacher group
Number of subjects: 99
Study: 17042248

Group type: EXPERIMENTAL
Intervention: Caffeinated tube food (200 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo tube food
Number of subjects: 12
Study: 12953899

Group type: EXPERIMENTAL
Intervention: Portal MU subtraction
Number of subjects: 11

Group type: COMPARATOR
Intervention: Portal filming without MU subtraction
Number of subjects: 11
Study: 10775736

Group type: EXPERIMENTAL
Intervention: Controlled-release oxybutynin
Number of subjects: 226

Group type: COMPARATOR
Intervention: Immediate-release oxybutynin
Number of subjects: 226
Study: 9068331

Group type: EXPERIMENTAL
Intervention: Propofol (n = 26, median dose 157 mg over 70 s)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Etomidate (n = 25, median dose 16.2 mg in 57 s)
Number of subjects: 51
Study: 8311162

Group type: EXPERIMENTAL
Intervention: Gestrinon
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Danason
Number of subjects: 58

Group type: COMPARATOR
Intervention: Menstrual fluid of patients with profuse uterine bleedings
Number of subjects: 58
Study: 3518527

Group type: EXPERIMENTAL
Intervention: Purified and standardized Cladosporium herbarum allergen preparation (active treatment)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Histamine placebo (control)
Number of subjects: 0
Study: 31331339

Group type: EXPERIMENTAL
Intervention: Routine follow-up (RFU) with one extra medical visit and additional visits to the Cardiology and Respiratory Medicine Clinics 1 and 3 months postoperatively
Number of subjects: 198

Group type: COMPARATOR
Intervention: Routine follow-up (RFU)
Number of subjects: 198
Study: 28836375

Group type: EXPERIMENTAL
Intervention: Motivational Interviewing (MI) session before periodontal treatment
Number of subjects: 26

Group type: COMPARATOR
Intervention: Conventional educational intervention and non-surgical periodontal therapy
Number of subjects: 26
Study: 27716125

Group type: EXPERIMENTAL
Intervention: Dysphagia-optimised intensity-modulated radiotherapy (Do-IMRT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard intensity-modulated radiotherapy (S-IMRT)
Number of subjects: 0
Study: 24681572

Group type: EXPERIMENTAL
Intervention: Nitrate-rich concentrated beetroot juice (NIT; nitrate dosage, approximately 9.7 mmol·d)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Nitrate-rich concentrated beetroot juice (NIT)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 19
Study: 22198714

Group type: EXPERIMENTAL
Intervention: Colonoscopy
Number of subjects: 8844

Group type: COMPARATOR
Intervention: CT-colonography
Number of subjects: 8844
Study: 20545407

Group type: EXPERIMENTAL
Intervention: Functional Family Therapy (FFT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Probation services (Control)
Number of subjects: 0
Study: 17549677

Group type: EXPERIMENTAL
Intervention: Levofloxacin formulation product after oral administration
Number of subjects: 0
Study: 16208152

Group type: EXPERIMENTAL
Intervention: HCTZ 25 mg added to olmesartan 20 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Olmesartan/HCTZ 20/12.5 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Olmesartan/HCTZ 20/25 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: HCTZ 12.5 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: HCTZ 25 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo added to olmesartan
Number of subjects: 0
Study: 11149993

Group type: EXPERIMENTAL
Intervention: EDTA
Number of subjects: 18

Group type: COMPARATOR
Intervention: BAC (positive control)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Normal saline (placebo)
Number of subjects: 18
Study: 9893775

Group type: EXPERIMENTAL
Intervention: Controlled release oral salbutamol (CR) 8 mg b.d. for > or = 3 days
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High-dose inhaled salmeterol xinafoate (SX) 100 micrograms b.d. for > or = 3 days
Number of subjects: 0
Study: 7924887

Group type: EXPERIMENTAL
Intervention: 1,5-anhydroglucitol (AG) quantitation method
Number of subjects: 15
Study: 3410812

Group type: EXPERIMENTAL
Intervention: Speech Alone
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Simultaneous Presentation of Sign and Speech
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Alternating Presentation of Sign and Speech
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sign Alone
Number of subjects: 60
Study: 30547847

Group type: EXPERIMENTAL
Intervention: SUMMIT intervention
Number of subjects: 100

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 100
Study: 26713333

Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide (50 mg per day)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 25205864

Group type: COMPARATOR
Intervention: Genetic variants rs1061170 (CFH) and rs10490924 (ARMS2) in European Americans
Number of subjects: 0

Group type: COMPARATOR
Intervention: Genetic variant rs10490924 (ARMS2) in Mexican Americans
Number of subjects: 0

Group type: COMPARATOR
Intervention: Lipid-associated SNPs (LPL rs328, TRIB1 rs6987702, CETP rs1800775, KCTD10/MVK rs2338104) in African Americans and Mexican Americans
Number of subjects: 0
Study: 22909321

Group type: EXPERIMENTAL
Intervention: Yoga
Number of subjects: 200

Group type: COMPARATOR
Intervention: Physical Activity
Number of subjects: 200
Study: 20628384

Group type: EXPERIMENTAL
Intervention: Direct referral for colposcopy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Repeated testing among HPV-positive/cytology-negative women
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not specified
Number of subjects: 0
Study: 17509336

Group type: EXPERIMENTAL
Intervention: Double‐J stent
Number of subjects: 201

Group type: COMPARATOR
Intervention: No-stent
Number of subjects: 201
Study: 15629562

Group type: EXPERIMENTAL
Intervention: CPREzy
Number of subjects: 20

Group type: COMPARATOR
Intervention: Standard CPR
Number of subjects: 20
Study: 12564619

Group type: EXPERIMENTAL
Intervention: HbA1c analysis using Tosoh method
Number of subjects: 430
Study: 10817105

Group type: EXPERIMENTAL
Intervention: Bupropion SR (100-300 mg/day)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Paroxetine (10-40 mg/day)
Number of subjects: 100
Study: 8788597

Group type: EXPERIMENTAL
Intervention: FK453 (50 mg)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: FK453 (200 mg)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study: 1345050

Group type: EXPERIMENTAL
Intervention: Active antihypertensive therapy
Number of subjects: 1627

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1627
Study: 6436935

Group type: EXPERIMENTAL
Intervention: 300 mg sustained release theophylline
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 450 mg sustained release theophylline
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 300 mg and 450 mg sustained release theophylline
Number of subjects: 16
Study: 30696471

Group type: EXPERIMENTAL
Intervention: Automated VR cognitive treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: VR mental relaxation (control condition)
Number of subjects: 0
Study: 28966154

Group type: EXPERIMENTAL
Intervention: Cortical bone trajectory-pedicle screw (CS)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Conventional pedicle screw (PS)
Number of subjects: 79
Study: 26850472

Group type: EXPERIMENTAL
Intervention: Road Traffic Injuries (RTIs)
Number of subjects: 5148

Group type: EXPERIMENTAL
Intervention: Household impact of RTIs
Number of subjects: 5148
Study: 24215774

Group type: EXPERIMENTAL
Intervention: Social and mobile weight loss intervention
Number of subjects: 404

Group type: COMPARATOR
Intervention: Informational web‐based weight loss program
Number of subjects: 404
Study: 22270284

Group type: COMPARATOR
Intervention: Transobturator tape (TOT)
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: Tension-free vaginal tape (TVT)
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: Quality-of-life outcomes (both groups)
Number of subjects: 164
Study: 20183394

Group type: EXPERIMENTAL
Intervention: Group therapy processes measured by the Working Alliance Inventory‐Short Form
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: Merged three‐factor model consisting of member‐leader alliance, positive bonding relationship, and negative relationship
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: Member-leader bonding
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: Cohesion and alliance
Number of subjects: 145
Study: 17973865

Group type: EXPERIMENTAL
Intervention: N(G)-monomethyl-L-arginine (L-NMMA) at 1 mmol/L
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Asymmetric dimethylarginine (ADMA) at 1 mmol/L
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: L-leucine at 1 mmol/L
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Collagen-induced platelet aggregation
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Basal NOS activity and intraplatelet cGMP levels
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Plasma concentrations of fibrinogen, C-reactive protein, and cytokines
Number of subjects: 30